Info@eximtradedata.com

Customs Turkey Import Data of Meta under HS Code 3002 from Belgium

Find the latest Customs Turkey import data of Meta under HS Code 05010000 from Belgium. Get in-depth insights into the shipment activities of top buyers from Turkey. Get genuine buyers from Turkey and increase your sales through our Turkey database. Establish a strong market presence in Turkey with the help of our data. Find Turkey imports from Belgium by HS Code, Quantity, Price, Importer name, Exporter name, and port of loading.

Filters
DateHS CodeProduct DetailsQuantityUnitTotal Value (USD)PortBuyer
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA6UNIT28720N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19382N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA8UNIT38516N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA2UNIT9982N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/15/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA10UNIT47958N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA10UNIT47649N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19251N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAB 25MG/ML 4ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19266N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/28/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA4UNIT19277N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
3/19/2024300214000000PEMBROLIZUMAN 25MG/ML 4 ML WITHDRAWABLE FROM THE STUDY COMPATING FIANLIMAB CEMIPLIMAB WITH +PEMBROLIZUMAB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTIC MELANOMA2UNIT9697N/AICON ANKARA KLİNİK ARAŞTIRMA DIŞ TİCARET ANONİM ŞİRKETİ
Know your Market & Competitor
Get Genuine Business Leads
Achieve your business goals
Customized Indonesia Data Reports
Fast & Reliable Services